Stock Price
TSX:MDS
PRICE: $
CHANGE:
VOLUME:47,191
NYSE:MDZ
PRICE: $
CHANGE:
VOLUME:122,758
Investor Information
67.2 million shares outstanding
(Jul 31, 2010)
Market cap of
C$652.5M
(July 31, 2010)
Name Change
Shareholders of MDS Inc. have approved a change of name from MDS Inc. to Nordion Inc. The company anticipates that the name change will be finalized in Q4 2010. As such, you will see references to both MDS Inc. and MDS Nordion on this website.
Investor Overview
Welcome to the MDS Investor Relations section. Here you will find the latest information on the value of MDS — from financial data and shareholder services, to reports and events.
Corporate Profile:
MDS Inc. is a global health science company that provides market-leading products and services used for the prevention, diagnosis and treatment of disease. We are a leading provider of innovative technologies for use in medical imaging and radiotherapeutics, and sterilization technologies benefiting the lives of millions of people in more than 65 countries around the world. Our products and services are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories.
MDS Nordion is a leading global provider of innovative technologies for medical imaging and radiotherapeutics, and sterilization. It operates in an estimated US$4 billion market.
MDS was founded in 1969 and currently has more than 850 highly skilled people in five locations.
MDS trades on the Toronto Stock Exchange (TSX: MDS) and on the New York Stock Exchange (NYSE: MDZ).